Abstract
The biologic agents are effective drugs to treat psoriasis. They provide physicians with additional options for patients who cannot tolerate traditional therapies or for whom traditional therapies are not sufficient. While these new TNF-α inhibitors and anti-T-cell agents have potential complications, they are generally safe with proper monitoring. Both physicians and patients should be aware of the risks involved with each medicine so that the correct drug is chosen to suit each patient.
Original language | English |
---|---|
Pages (from-to) | 207-213 |
Number of pages | 7 |
Journal | Dermatologic Clinics |
Volume | 25 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2007 |